Drug class in one race
JAK1 drugs for Rheumatoid Arthritis
2 tracked JAK1 drugs in the Rheumatoid Arthritis race. The class explanation lives on the JAK1 page; the full indication pipeline across every mechanism is on the Rheumatoid Arthritis page.
1 approved / phase 41 Phase 3
Head-to-head evidence: filgotinib vs upadacitinib